These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19276049)

  • 1. Vascular pathology in male Lewis rats following short-term, low-dose rotenone administration.
    Allen AL; Luo C; Montgomery DL; Rajput AH; Robinson CA; Rajput A
    Vet Pathol; 2009 Jul; 46(4):776-82. PubMed ID: 19276049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep disturbances in the rotenone animal model of Parkinson disease.
    García-García F; Ponce S; Brown R; Cussen V; Krueger JM
    Brain Res; 2005 May; 1042(2):160-8. PubMed ID: 15854587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.
    Caboni P; Sherer TB; Zhang N; Taylor G; Na HM; Greenamyre JT; Casida JE
    Chem Res Toxicol; 2004 Nov; 17(11):1540-8. PubMed ID: 15540952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.
    Ravenstijn PG; Merlini M; Hameetman M; Murray TK; Ward MA; Lewis H; Ball G; Mottart C; de Ville de Goyet C; Lemarchand T; van Belle K; O'Neill MJ; Danhof M; de Lange EC
    J Pharmacol Toxicol Methods; 2008; 57(2):114-30. PubMed ID: 18155613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular damage mediates neuronal and non-neuronal pathology following short and long-term rotenone administration in Sprague-Dawley rats.
    Radad K; Hassanein K; Moldzio R; Rausch WD
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):41-7. PubMed ID: 21676605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein and tyrosine hydroxylase expression in acute rotenone toxicity.
    Luo C; Rajput AH; Akhtar S; Rajput A
    Int J Mol Med; 2007 Mar; 19(3):517-21. PubMed ID: 17273802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease.
    Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI
    Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism.
    Pasha MK; Sharma RK; Rajput AH
    Int J Mol Med; 2005 Jun; 15(6):987-91. PubMed ID: 15870904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
    Sonia Angeline M; Sarkar A; Anand K; Ambasta RK; Kumar P
    Neuroscience; 2013 Dec; 254():379-94. PubMed ID: 24070629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson's disease.
    Johnson ME; Stringer A; Bobrovskaya L
    Neurotoxicology; 2018 Mar; 65():174-185. PubMed ID: 29471018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pesticide use linked to Parkinson's disease.
    Adam D
    Nature; 2000 Nov; 408(6809):125. PubMed ID: 11089940
    [No Abstract]   [Full Text] [Related]  

  • 13. Overexpression of Kir2.3 in PC12 cells resists rotenone-induced neurotoxicity associated with PKC signaling pathway.
    Wang G; Zeng J; Shen CY; Wang ZQ; Chen SD
    Biochem Biophys Res Commun; 2008 Sep; 374(2):204-9. PubMed ID: 18619942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication.
    Panov A; Dikalov S; Shalbuyeva N; Taylor G; Sherer T; Greenamyre JT
    J Biol Chem; 2005 Dec; 280(51):42026-35. PubMed ID: 16243845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from the rotenone model of Parkinson's disease.
    Greenamyre JT; Cannon JR; Drolet R; Mastroberardino PG
    Trends Pharmacol Sci; 2010 Apr; 31(4):141-2; author reply 142-3. PubMed ID: 20096940
    [No Abstract]   [Full Text] [Related]  

  • 16. Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.
    Wang Y; Liu W; Yang J; Wang F; Sima Y; Zhong ZM; Wang H; Hu LF; Liu CF
    Neurotoxicology; 2017 Jan; 58():103-109. PubMed ID: 27866991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity.
    Belcastro V; Tozzi A; Tantucci M; Costa C; Di Filippo M; Autuori A; Picconi B; Siliquini S; Luchetti E; Borsini F; Calabresi P
    Exp Neurol; 2009 May; 217(1):231-4. PubMed ID: 19416678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.
    Falk T; Zhang S; Sherman SJ
    Neurosci Lett; 2009 Jul; 458(2):49-52. PubMed ID: 19442875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: possible synergy of neurotoxins.
    Caparros-Lefebvre D; Steele J; Kotake Y; Ohta S
    Mov Disord; 2006 Oct; 21(10):1769-71. PubMed ID: 16874753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.